Nanofin-d2
Nanofin-d2 (2,6-Lupetidine-d2) is the d2-labeled Nanofin (HY-B1191). Nanofin (2,6-Lupetidine) is a ganglionic blocker. Nanofin is used in research on eczema, neurodermatitis and hypertension.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C7H13D2N
- Molecular Weight:115.21
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Anwendung
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled CAS 504-03-0
-
Molecular Weight 115.21
-
Formel C7H13D2N
-
SMILES
CC1([2H])CCCC(C)([2H])N1
-
Synonyms
2,6-Lupetidine-d2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)